RISEDRONATE EVOLUGEN 75 mg, film-coated tablet 6 tablets
Active ingredients: Risedronate sodium, Risedronate sodium hemi-pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet6 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RISEDRONATE EVOLUGEN 75 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 6 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Jun 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61875194CIP73025273CIP133400930252734Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISÉDRONATE MONOSODIQUE ANHYDREcomprimé | 75 mg · un comprimé | FT |
| RISÉDRONATE MONOSODIQUE HÉMIPENTAHYDRATÉcomprimé | 86,07 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.